Windtree Announces Issuance of Composition of Matter Patent for Dual Mechanism SERCA2a Activators by the US Patent and Trademark Office

<p>Patent provides protection through late 2039 for drug candidates with potential to improve cardiac function in heart failure patients WARRINGTON, Pa., Aug. 23, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, today reported that the United States Patent and […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/windtree-announces-issuance-of-composition-of-matter-patent-for-dual-mechanism-serca2a-activators-by-the-us-patent-and-trademark-office/">Windtree Announces Issuance of Composition of Matter Patent for Dual Mechanism SERCA2a Activators by the US Patent and Trademark Office</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>